Point72 Middle East FZE’s AbCellera Biologics ABCL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-4,704	Closed	-$30.4K	–	857
2023 Q2	$30.4K	Buy	+4,704	New	+$30.4K	﹤0.01%	812
2023 Q1	–	Sell	-15,031	Closed	-$152K	–	1024
2022 Q4	$152K	Buy	+15,031	New	+$152K	0.01%	643